Drug Company

Feb 23, 2015 at 15:17 | Source: Reuters
The FDA inspected the plant in January this year, after which it issued the company a so-called Form 483, listing six observations on the manufacturing processes at the plant, Lupin said in a statement, without giving details.
Feb 20, 2015 at 12:28 | Source:
Beryl Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 20, 2015, has considered and approved delisting of securities from M.P. Stock Exchange.
Feb 17, 2015 at 15:35 | Source: PTI
Lupin and Celon Pharma SA have entered into a definitive agreement under which the companies will jointly develop fluticasone/salmeterol dry powder inhaler (DPI) product which is a generic version of GlaxoSmithKline's Advair Diskus, the Mumbai-based firm said in a statement.
Feb 13, 2015 at 15:03 | Source:
Beryl Drugs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 20, 2015, to consider and approve the delisting of securities from M.P. Stock Exchange.
Feb 12, 2015 at 20:56 | Source: PTI
"Pursuant to the global deal, the company will have its distribution rights terminated for the oncology portfolio in return for accessing the distribution rights of the acquired vaccines portfolio," GlaxoSmithKline Pharmaceuticals Ltd said in a filing to the BSE.
Feb 12, 2015 at 19:10 | Source:
Kilitch Drugs India has informed that the Board of Directors of the Company at its meeting held on February 12, 2015, has transacted the following: 1. The Board approved the appointment of M/s. Deep Shukla & Associates, Company Secretaries to conduct Secretarial Audit of the Company for the financial year ended March 31, 2015.
Feb 11, 2015 at 19:30 | Source:
Godavari Drugs has informed that the Board of Directors of the Company at its meeting held on February 11, 2015, have taken the following decisions: 1. Appointment of Mr. Jeevan Innani as a Company Secretary. 2. To initiate postal ballot and e-voting process, to appoint Independent Directors on the Board of the Company.
Feb 11, 2015 at 11:51 | Source: CNBC-TV18
For investing, one should look at getting into fundamentally sound stocks and sectors that have consistently performed but the wait could be longer, says Nipun Mehta of Blue Ocean Capital Advisors.
Feb 06, 2015 at 15:55 | Source:
Mangalam Drugs & Organics Ltd has informed BSE that Mr. Rajendra Prasad Mimani has resigned as Director from the Board of the Company. The resignation is effective from February 03, 2015.
Jan 27, 2015 at 22:22 | Source: CNBC-TV18
Ranbaxy has lost out on its last big drug opportunity in the US market. The US drug regulator has denied the company 180-day exclusivity for the generic version of heart burn drug Nexium. However Archana Shukla reports that Ranbaxy's loss means good times for global rival Teva and Cipla.
Messages on Drug Company »


Gold Member


Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th 2014

anil patil

Platinum Member


Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st 2014


Platinum Member


Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th 2014


New Member



Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th 2014


Platinum Member



, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd 2014


New Member


Aurobindo Pharm buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th 2014

Web Messenger

Platinum Member


Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th 2014


Platinum Member


Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th 2014


Gold Member


Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th 2014

Web Messenger

Platinum Member



Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st 2014

News across the web »
Feb 19, 2015 at 23:46 | Source: FirstPost
Jan 24, 2015 at 02:30 | Source: FirstPost
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.